(No ratings)
Dr. Steve Rad, MD is a perinatologist in Santa Monica, CA specializing in maternal and fetal medicine. He graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine. Dr. Steve Rad, MD is affiliated with California Hospital Medical Center, Dignity Health, Cedars-Sinai and Los Angela Fetal Maternal Center.
Dignity Health
Dr. Steve Rad, MD graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine. He completed residency at Cedars-Sinai Medical Center. He is certified by the Obstetrics & Gynecology and has a state license in California.
Medical School: University of California, Los Angeles (UCLA), David Geffen School of Medicine
Residency: Cedars-Sinai Medical Center
Board Certification: Obstetrics & Gynecology
Licensed In: California
Dr. Steve Rad, MD is associated with these hospitals and organizations:
Dr. Steve Rad, MD does not have any reviews yet, be the first to leave a review of Dr. Steve Rad, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Steve Rad, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Alexion Pharmaceuticals, Inc. |
$3,342
SOLIRIS $3,342 |
|
|---|---|---|
| Vitrolife Inc. |
$174
$174 |
|
| GE Healthcare |
$142
$142 |
|
| Boehringer Ingelheim Pharmaceuticals, Inc. |
$117
JARDIANCE $117 |
|
| Shield Therapeutics Inc |
$21
ACCRUFER $21 |
|
| Other |
$27
PARAGARD $16 |
Makena $11 |
| Consulting Fee | $2,400 |
|---|---|
| Travel and Lodging | $783 |
| Food and Beverage | $629 |
| Education | $11 |
Dr. Steve Rad's medical specialty is maternal and fetal medicine. In addition to English, he speaks Spanish. His areas of expertise include women's health issues. Dr. Rad is professionally affiliated with Cedars-Sinai. He studied medicine at the University of California, Los Angeles (UCLA), David Geffen School of Medicine. Dr. Rad's residency was performed at Cedars-Sinai Medical Center. He is not accepting new patients at this time according to Cedars-Sinai.